2-136114925-C-T
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP4_ModerateBS2
The NM_003467.3(CXCR4):c.1003G>A(p.Gly335Ser) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.00013 in 1,612,178 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_003467.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -6 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CXCR4 | NM_003467.3 | c.1003G>A | p.Gly335Ser | missense_variant | 2/2 | ENST00000241393.4 | NP_003458.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CXCR4 | ENST00000241393.4 | c.1003G>A | p.Gly335Ser | missense_variant | 2/2 | 1 | NM_003467.3 | ENSP00000241393.3 |
Frequencies
GnomAD3 genomes AF: 0.0000788 AC: 12AN: 152208Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000605 AC: 15AN: 247912Hom.: 0 AF XY: 0.0000597 AC XY: 8AN XY: 133906
GnomAD4 exome AF: 0.000136 AC: 198AN: 1459970Hom.: 0 Cov.: 31 AF XY: 0.000131 AC XY: 95AN XY: 726046
GnomAD4 genome AF: 0.0000788 AC: 12AN: 152208Hom.: 0 Cov.: 33 AF XY: 0.0000807 AC XY: 6AN XY: 74354
ClinVar
Submissions by phenotype
not provided Uncertain:3
Uncertain significance, criteria provided, single submitter | clinical testing | GeneDx | Nov 18, 2022 | Identified in an individual with familial chronic lymphocytic leukemia (Crowther-Swanepoel et al., 2009); however, familial segregation analysis was not performed and additional clinical details were not provided; In silico analysis supports that this missense variant does not alter protein structure/function; This variant is associated with the following publications: (PMID: 27268124, 19812382, 33735664) - |
Uncertain significance, criteria provided, single submitter | clinical testing | Mayo Clinic Laboratories, Mayo Clinic | Aug 19, 2019 | - - |
Uncertain significance, criteria provided, single submitter | clinical testing | Eurofins Ntd Llc (ga) | Feb 26, 2018 | - - |
not specified Uncertain:1
Uncertain significance, no assertion criteria provided | clinical testing | Genetic Services Laboratory, University of Chicago | Sep 19, 2022 | DNA sequence analysis of the CXCR4 gene demonstrated a sequence change, c.1003G>A, in exon 2 that results in an amino acid change, p.Gly335Ser. This sequence change does not appear to have been previously described in individuals with CXCR4-related disorders. This sequence change has been described in the gnomAD database with a frequency of 0.013% in the European subpopulation (dbSNP rs147214773). The p.Gly335Ser change affects a moderately conserved amino acid residue located in a domain of the CXCR4 protein that is known to be functional. The p.Gly335Ser substitution appears to be benign using several in-silico pathogenicity prediction tools (SIFT, PolyPhen2, Align GVGD, REVEL). This sequence change has been reported in one individual with familial chronic lymphocytic leukemia (PMID:19812382). Due to insufficient evidences and the lack of functional studies, the clinical significance of the p.Gly335Ser change remains unknown at this time. - |
Warts, hypogammaglobulinemia, infections, and myelokathexis Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Dec 17, 2023 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at